AssayIndex
Reports by quarter

Reports submitted in 2024-Q1

Backfill quarter. Reports assayed earlier were accepted retrospectively where custody could be documented. Median purity for the quarter is 99.09 % area, n=163. Read the 2024-Q1 state-of-the-index report →

163 records5 pagesmedian on this page 99.12 %updated 30 Jul 2026
08162492.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=096.75–97.00 %: n=497.00–97.25 %: n=197.25–97.50 %: n=397.50–97.75 %: n=897.75–98.00 %: n=798.00–98.25 %: n=998.25–98.50 %: n=498.50–98.75 %: n=1098.75–99.00 %: n=2499.00–99.25 %: n=2799.25–99.50 %: n=2199.50–99.75 %: n=1999.75–100.00 %: n=26median 99.09 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2024-Q1. n=163, median 99.09 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-005302SemaglutideGL BiochemGLBI-2401-F8702PeptideMeter2024-Q198.843.00—Laboratory-retained1MARGINAL
AX-2024-004674TirzepatideTFCTFC-2401-J7929Janoshik2024-Q198.746.39101.4Supplier-supplied2MARGINAL
AX-2024-004429TirzepatideQSCQSC-2402-D9020VendorInvestigate2024-Q198.663.60—Buyer-sourced1MARGINAL
AX-2024-005369SemaglutideCPCCPC-2309-A2449VendorInvestigate2024-Q197.495.39102.2Laboratory-retained1MARGINAL
AX-2024-004767N-Acetyl Semax AmideHomopeptideHOMO-2401-X1480Janoshik2024-Q199.367.8294.0Supplier-supplied0PASS
AX-2024-004776N-Acetyl Semax AmideHomopeptideHOMO-2401-X1480Medutest2024-Q199.668.17106.7Supplier-supplied0PASS
AX-2024-004432TB-500QSCQSC-2311-E9215Janoshik2024-Q199.824.67104.1Supplier-supplied1MARGINAL
AX-2024-004766N-Acetyl Semax AmideHomopeptideHOMO-2401-X1480Nordanalyt2024-Q199.478.97100.2Supplier-supplied0PASS
AX-2024-004342PT-141 (Bremelanotide)QSCQSC-2402-X7410VendorInvestigate2024-Q199.442.86—Buyer-sourced0PASS
AX-2024-005445TirzepatideWXTWXT-2402-L6189Nordanalyt2024-Q196.936.8694.7Buyer-sourced1FAIL
AX-2024-004777N-Acetyl Semax AmideHomopeptideHOMO-2401-X1480Medutest2024-Q199.938.28—Supplier-supplied0PASS
AX-2024-004247AfamelanotideWWBWWB-2312-P4483Janoshik2024-Q199.743.76—Supplier-supplied1MARGINAL
AX-2024-004288TirzepatideQYBQYB-2402-J5424VendorInvestigate2024-Q197.733.5090.9Buyer-sourced1MARGINAL
AX-2024-005365SemaglutideCPCCPC-2309-A2449Medutest2024-Q196.824.81103.0Supplier-supplied1FAIL
AX-2024-005331GHRP-6SGNSGN-2401-B9048Janoshik2024-Q199.593.9393.4Supplier-supplied1MARGINAL
AX-2024-005304SemaglutideGL BiochemGLBI-2401-F8702VendorInvestigate2024-Q198.873.25100.7Buyer-sourced1MARGINAL
AX-2024-004848RetatrutideHJHJ-2309-J4137VendorInvestigate2024-Q198.926.4698.6Buyer-sourced1MARGINAL
AX-2024-004125SemaxWWBWWB-2308-N1754Janoshik2024-Q199.665.7491.6Supplier-supplied1MARGINAL
AX-2024-004682TirzepatideTFCTFC-2401-J7929Janoshik2024-Q198.916.67—Supplier-supplied2MARGINAL
AX-2024-004248AfamelanotideWWBWWB-2312-P4483Janoshik2024-Q199.933.8694.6Supplier-supplied1MARGINAL
AX-2024-004850RetatrutideHJHJ-2309-J4137Janoshik2024-Q198.756.65103.1Laboratory-retained2MARGINAL
AX-2024-004769N-Acetyl Semax AmideHomopeptideHOMO-2401-X1480Medutest2024-Q199.318.63—Supplier-supplied0PASS
AX-2024-005373SemaglutideCPCCPC-2309-A2449Janoshik2024-Q197.735.14102.3Buyer-sourced2FAIL
AX-2024-004427TirzepatideQSCQSC-2402-H8701Janoshik2024-Q199.202.19—Supplier-supplied1MARGINAL
AX-2024-004414Melanotan IIQSCQSC-2402-L8184Medutest2024-Q199.355.49102.2Supplier-supplied2MARGINAL
AX-2024-004287TirzepatideQYBQYB-2402-J5424Janoshik2024-Q199.493.72103.6Supplier-supplied3FAIL
AX-2024-004243AfamelanotideWWBWWB-2312-P4483Janoshik2024-Q199.292.79102.3Supplier-supplied1MARGINAL
AX-2024-005328GHRP-6SGNSGN-2401-B9048VendorInvestigate2024-Q199.264.38—Buyer-sourced1MARGINAL
AX-2024-004344PT-141 (Bremelanotide)QSCQSC-2402-X7410VendorInvestigate2024-Q198.744.05—Buyer-sourced0PASS
AX-2024-004570SemaglutideJEEPJEEP-2308-J3560Janoshik2024-Q198.875.0399.2Supplier-supplied1MARGINAL
AX-2024-004423TirzepatideQSCQSC-2402-H8701Janoshik2024-Q199.041.12—Supplier-supplied1MARGINAL
AX-2024-004155DesmopressinWWBWWB-2312-E2908Nordanalyt2024-Q199.445.24100.3Supplier-supplied0PASS
AX-2024-004672TirzepatideTFCTFC-2401-J7929PeptideMeter2024-Q197.636.85—Supplier-supplied2MARGINAL
AX-2024-004122SemaxWWBWWB-2308-N1754Janoshik2024-Q199.365.6191.6Supplier-supplied1MARGINAL
AX-2024-005518AfamelanotideBCHBCH-2310-K7610Medutest2024-Q198.115.5197.1Supplier-supplied0PASS
AX-2024-004660RetatrutideTFCTFC-2309-H6661Kestrel2024-Q199.194.41101.1Supplier-supplied1MARGINAL
AX-2024-004285TirzepatideQYBQYB-2402-J5424Janoshik2024-Q199.003.7798.7Supplier-supplied2MARGINAL
AX-2024-004756TB-500HomopeptideHOMO-2308-R8982VendorInvestigate2024-Q198.863.96100.4Buyer-sourced3MARGINAL
AX-2024-004852RetatrutideHJHJ-2309-J4137Janoshik2024-Q199.595.82105.1Supplier-supplied1MARGINAL
AX-2024-004677TirzepatideTFCTFC-2401-J7929Janoshik2024-Q197.906.80—Supplier-supplied2MARGINAL